• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
GSS

GENETIC SIGNATURES LIMITED - News & Media

0.00% ! 8.0¢
Market Cap $18.17M  !

Genetic Signatures Limited is an Australia-based specialist molecular diagnostics (MDx)... Genetic Signatures Limited is an Australia-based specialist molecular diagnostics (MDx) company. The Company's principal activities include research and commercialization of identifying individual genetic signatures to identify diseases and the sale of associated products into the diagnostic and research marketplaces. The Company is focused on the development and commercialization of its platform technology, 3base. Its MDx 3base platform technology provides high-volume hospitals and pathology laboratories with the ability to screen for an array of infectious pathogens, with a high degree of specificity, in a rapid throughput (time-to-result) environment. It designs and manufactures a suite of real-time Polymerase Chain Reaction (PCR) based products for the routine detection of infectious diseases under the EasyScreen brand. Its products include EasyScreen Pan-Enteric Detection Kit, EasyScreen STI Genital Pathogen Detection, EasyScreen Viral Meningitis Detection Kit, and others. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $18.17M
Open High Low Volume
0.0¢ 0.0¢ 0.0¢ 0

Buyers (Bids)

Vol. Price($)
64000 8.1¢
 

Sellers (Offers)

Price($) Vol.
10.5¢ 17087
Last trade - 11.47am 10/04/2026 (20 minute delay) ?
GSS (ASX) Chart
Day chart unavailable
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.